{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:17:08Z","timestamp":1788517028761,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Instituto Nacional De C\u00e2ncer Jos\u00e9 Alencar Gomes Da Silva"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The activation of the Wnt\/\u03b2-catenin pathway with chemoresistance in colorectal cancer has been hypothesized. However, the use of specific inhibitors for targeting this pathway has not been well explored. In the present study, we analyze the activation of this pathway and its role in the stemness phenotype acquisition to regulate chemoresistance using our long-term 5-fluorouracil (5-FU) \u2010 resistant model of colorectal cancer cells, known to present epithelial-mesenchymal transition and enhanced migration and invasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      Initially by bioinformatic analyses we demonstrate the association between 5-FU resistance genes with those of a stem cell-like phenotype in patients with colon cancer. In addition, 5-FU-resistant cells displayed stemness characteristics, with upregulation of key stem cell marker (\n                      <jats:italic>ALDH1A1<\/jats:italic>\n                      ) using reverse transcription-quantitative polymerase chain reaction. Further, 5-FU-resistant cells exhibited high Wnt\/\u03b2-catenin pathway activity. Interestingly, treatment with LF3, an inhibitor of this pathway, re-sensitized the 5-FU-resistant cells, decreasing their proliferation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Wnt\/\u03b2-catenin pathway activation plays a role in regulating key cellular events involved in chemoresistance. The study findings suggest the use of combinatorial therapies using conventional agents, such as 5-FU, and inhibitors of this pathway, as a useful therapeutic strategy to treat patients with colorectal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11033-026-12711-z","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:00:43Z","timestamp":1788516043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological inhibition of the canonical Wnt\/\u03b2-catenin signaling pathway sensitizes 5-fluorouracil-resistant colorectal cancer cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Diego Alfonso Arregui","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Filomena Tavares","family":"de Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie Cristhine Moraes","family":"Sousa-Squiavinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace Martins","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murilo Ramos","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-9958","authenticated-orcid":false,"given":"Jose Andres","family":"Morgado-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"12711_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Loversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"12711_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung H, Siegel R, Laversanne M et al (2025) Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol 26:51\u201363. https:\/\/doi.org\/10.1016\/S1470-2045(24)00600-4","journal-title":"Lancet Oncol"},{"key":"12711_CR3","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","volume":"68","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Torre LA, Soerjomataram I et al (2019) Global patterns and trends in colorectal cancer incidence in young adults. Gut 68:2179\u20132185. https:\/\/doi.org\/10.1136\/gutjnl-2019-319511","journal-title":"Gut"},{"key":"12711_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/jcb.30361","volume":"124","author":"JW Tessmann","year":"2023","unstructured":"Tessmann JW, Rocha MR, Morgado-Diaz JA (2023) Mechanisms of radioresistance and the underlying signaling pathways in colorectal cancer cells. J Cell Biochem 124:31\u201345. https:\/\/doi.org\/10.1002\/jcb.30361","journal-title":"J Cell Biochem"},{"key":"12711_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H (2017) Cancer stem cells revisited. Nat Med 23:1124\u20131134. https:\/\/doi.org\/10.1038\/nm.4409","journal-title":"Nat Med"},{"key":"12711_CR6","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.12688\/f1000research.15782.1","volume":"18","author":"S Basu","year":"2018","unstructured":"Basu S, Cheriyamundath S, Ben-Ze\u2019ev A (2018) Cell-cell adhesion: linking Wnt\/\u03b2-catenin signaling with partial EMT and stemness traits in tumorigenesis. F1000Res 18:1488. https:\/\/doi.org\/10.12688\/f1000research.15782.1","journal-title":"F1000Res"},{"key":"12711_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116848","volume":"236","author":"J Zhang","year":"2025","unstructured":"Zhang J, Guo H, Gong C et al (2025) Therapeutic targets in the Wnt signaling pathway: treating cancer with specificity. Biochem Pharmacol 236:116848. https:\/\/doi.org\/10.1016\/j.bcp.2025.116848","journal-title":"Biochem Pharmacol"},{"key":"12711_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ijc.33811","volume":"150","author":"A Neiheisel","year":"2022","unstructured":"Neiheisel A, Kaur M, Ma N et al (2022) Wnt pathway modulators in cancer therapeutics: an update on completed and ongoing clinical trials. Int J Cancer 150:727\u2013740. https:\/\/doi.org\/10.1002\/ijc.33811","journal-title":"Int J Cancer"},{"key":"12711_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0615-3","volume":"11","author":"I Spaan","year":"2018","unstructured":"Spaan I, Raymakers RA, van de Stolpe A et al (2018) Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential. J Hematol Oncol 11:67. https:\/\/doi.org\/10.1186\/s13045-018-0615-3","journal-title":"J Hematol Oncol"},{"key":"12711_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S et al (2022) Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer 21:144. https:\/\/doi.org\/10.1186\/s12943-022-01616-7","journal-title":"Mol Cancer"},{"key":"12711_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.critrevonc.2015.12.005","volume":"16","author":"Y Duchartre","year":"2016","unstructured":"Duchartre Y, Kim YM, Kahn M (2016) The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol 16:141\u2013149. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.12.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"12711_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.26402\/jpp.2018.2.07","volume":"69","author":"B Taciak","year":"2018","unstructured":"Taciak B, Pruszynska I, Kiraga L et al (2018) Wnt signaling pathway in development and cancer. J Phisiol Pharmacol 69:185\u2013196. https:\/\/doi.org\/10.26402\/jpp.2018.2.07","journal-title":"J Phisiol Pharmacol"},{"key":"12711_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9390878","volume":"18","author":"S Yuan","year":"2020","unstructured":"Yuan S, Tao F, Zhang X et al (2020) Role of Wnt\/\u03b2-catenin signaling in the chemoresistance modulation of colorectal cancer. Biomed Res Int 18:9390878. https:\/\/doi.org\/10.1155\/2020\/9390878","journal-title":"Biomed Res Int"},{"key":"12711_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175253","volume":"933","author":"ACM Sousa-Squiavinato","year":"2022","unstructured":"Sousa-Squiavinato ACM, Arregui Ramos D, Wagner MS et al (2022) Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. Eur J Pharmacol 933:175253. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175253","journal-title":"Eur J Pharmacol"},{"key":"12711_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29703-0","volume":"8","author":"MR Rocha","year":"2018","unstructured":"Rocha MR, Barcellos-de-Souza P, Sousa-Squiavinato ACM et al (2018) Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-\u00df induced epithelial mesenchymal transition viaSrc\/ANXA2\/STAT3. Sci Rep 8:11285. https:\/\/doi.org\/10.1038\/s41598-018-29703-0","journal-title":"Sci Rep"},{"key":"12711_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2108690","volume":"23","author":"CD Fleming-de-Moraes","year":"2022","unstructured":"Fleming-de-Moraes CD, Rocha MR, Tessmann JW et al (2022) Crosstalk between PI3K\/Akt and Wnt\/\u03b2-catenin pathways promote colorectal cancer progression regardless of mutational status. Cancer Biol Ther 23:1\u201313. https:\/\/doi.org\/10.1080\/15384047.2022.2108690","journal-title":"Cancer Biol Ther"},{"key":"12711_CR17","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2174\/1381612826666200408102305","volume":"26","author":"H Wang","year":"2020","unstructured":"Wang H, Cui G, Yu B et al (2020) Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies. Curr Pharm Des 26:1979\u20131993. https:\/\/doi.org\/10.2174\/1381612826666200408102305","journal-title":"Curr Pharm Des"},{"key":"12711_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061392","volume":"9","author":"PK Das","year":"2020","unstructured":"Das PK, Islam F, Lam AK (2020) The roles of cancer stem cells and therapy resistance in colorectal carcinoma. Cells 9:1392. https:\/\/doi.org\/10.3390\/cells9061392","journal-title":"Cells"},{"key":"12711_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1026278","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Li Y, Chen Y et al (2022) ALDH1: a potential therapeutic target for cancer stem cells in solid tumors. Front Oncol 12:1026278. https:\/\/doi.org\/10.3389\/fonc.2022.1026278","journal-title":"Front Oncol"},{"issue":"9","key":"12711_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02958-0","volume":"42","author":"X Wang","year":"2025","unstructured":"Wang X, Wen X, Hu X et al (2025) ALDH1A1 promotes colorectal cancer metastasis through activating the notch signaling pathway. Med Oncol 42(9):403. https:\/\/doi.org\/10.1007\/s12032-025-02958-0","journal-title":"Med Oncol"},{"key":"12711_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03758-2","volume":"25","author":"A Babajnai","year":"2025","unstructured":"Babajnai A, Rahmani S, Asadi MJ et al (2025) Molecular and phenotypic characterization of 5-FU resistant colorectal cancer cells: toward enrichment of cancer stem cells. Cancer Cell Int 25:154. https:\/\/doi.org\/10.1186\/s12935-025-03758-2","journal-title":"Cancer Cell Int"},{"key":"12711_CR22","doi-asserted-by":"publisher","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy C, Kundu CN (2021) 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition. Biomed Pharmacother 137:111285. https:\/\/doi.org\/10.1016\/j.biopha.2021.111285","journal-title":"Biomed Pharmacother"},{"key":"12711_CR23","doi-asserted-by":"publisher","first-page":"33972","DOI":"10.18632\/oncotarget.15687","volume":"8","author":"S Shang","year":"2017","unstructured":"Shang S, Hua F, Hu ZW (2017) The regulation of \u03b2-catenin activity and function in cancer: therapeutic opportunities. Oncotarget 8:33972\u201333989. https:\/\/doi.org\/10.18632\/oncotarget.15687","journal-title":"Oncotarget"},{"key":"12711_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s12276-018-0128-8","volume":"50","author":"L He","year":"2018","unstructured":"He L, Zhu H, Zhou S et al (2018) Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells. Exp Mol Med 50:101. https:\/\/doi.org\/10.1038\/s12276-018-0128-8","journal-title":"Exp Mol Med"},{"key":"12711_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19173-2","volume":"11","author":"Y-H Cho","year":"2020","unstructured":"Cho Y-H, Ro EJ, Yoon J-S et al (2020) 5-FU promotes stemness of colorectal cancer via p53-mediated WNT\/\u03b2-catenin pathway activation. Nat Commun 11:5321. https:\/\/doi.org\/10.1038\/s41467-020-19173-2","journal-title":"Nat Commun"},{"key":"12711_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yjmcc.2019.08.007","volume":"135","author":"L Zhao","year":"2019","unstructured":"Zhao L, Sun L, Lu Y et al (2019) Small-molecule LF3 abrogates \u03b2- catenin\/TCF4-mediated suppression of NaV1.5 expression in HL-1 cardiomyocytes. J Mol Cell Cardiol 135:90\u201396. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.08.007","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"12711_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/0008-5472.CAN-15-1519","volume":"76","author":"L Fang","year":"2016","unstructured":"Fang L, Zhu Q, Neuenschwander M et al (2016) A Small-Molecule Antagonist of the \u03b2-Catenin\/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis. Cancer Res 76(4):891\u2013901. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1519","journal-title":"Cancer Res"},{"key":"12711_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","volume":"21","author":"M Bugter","year":"2021","unstructured":"Bugter M, Fenderico N, Maurice MM (2021) Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer 21:5\u201321. https:\/\/doi.org\/10.1038\/s41568-020-00307-z","journal-title":"Nat Rev Cancer"},{"key":"12711_CR29","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s12010-024-05072-5","volume":"197","author":"VP Warrier","year":"2025","unstructured":"Warrier VP, Venkatachalam S, Sakthivel R et al (2025) Combinatorial Effects of 5\u2013Fluorouracil and Menadione on Wnt\/\u03b2\u2013Catenin Pathway in Human Colorectal Cancer Cells. Appl Biochem Biotechnol 197:1280\u20131300. https:\/\/doi.org\/10.1007\/s12010-024-05072-5","journal-title":"Appl Biochem Biotechnol"},{"key":"12711_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cbin.12270","volume":"49","author":"MR Rocha","year":"2025","unstructured":"Rocha MR, Castillo-Medina YK, de Lima Coelho BM et al (2025) Wnt\/\u03b2-catenin pathway as a link between therapy resistance-driven epithelial-mesenchymal transition and stemness in colorectal cancer. Cell Biol Int 49:154\u2013160. https:\/\/doi.org\/10.1002\/cbin.12270","journal-title":"Cell Biol Int"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12711-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:00:44Z","timestamp":1788516044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12711"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12711-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1522"}}